Foster City, CA and Louisville, CO – October 24, 2011 – Gilead Sciences, Inc. (Nasdaq: GILD) and GlobeImmune, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of … Continue reading
Gilead and GlobeImmune Announce License and Collaboration Agreement to Develop Therapeutic Vaccine Products For Treatment of Chronic Hepatitis B Infection
October 24, 2011